A pharmacy receives the following prescription: Auvi-Q 0.3 mg/0.3 mL Sig: 0.3 mg PO p.r.n. for severe allergic reaction Disp: 2 pack. The prescriber should be contacted to clarify the:

Rationale

The prescriber should be contacted to clarify the route of administration.

The prescription specifies Auvi-Q 0.3 mg/0.3 mL, which is typically administered via an auto-injector for severe allergic reactions. However, the instruction "PO" (by mouth) is inappropriate for this medication, warranting clarification from the prescriber.

A (quantity to dispense) YOUR ANSWER

The quantity to dispense is clearly stated as "Disp: 2 pack," which provides sufficient information to the pharmacist. Since the prescription explicitly mentions the number of packs, this aspect does not require further clarification.

B (medication indication) YOUR ANSWER

The indication for use is also clear as it states "for severe allergic reaction." This provides a transparent understanding of why Auvi-Q is being prescribed, making it unnecessary to contact the prescriber for clarification on this point.

C (medication strength) YOUR ANSWER

The medication strength is specified as 0.3 mg/0.3 mL, which is standard for Auvi-Q. There is no ambiguity regarding the strength of the medication, so this choice does not require any further clarification from the prescriber.

D (route of administration) CORRECT

The route of administration should be clarified as the prescription indicates "PO" (by mouth), which is not appropriate for Auvi-Q, an auto-injector intended for subcutaneous injection. This discrepancy raises concerns about the correct method of administration that must be addressed.

Conclusion

In this case, the only aspect of the prescription that necessitates clarification is the route of administration. While the quantity, indication, and strength are all properly specified, the instruction to take Auvi-Q "PO" contradicts its intended use, making it crucial to confirm the correct administration method with the prescriber to ensure patient safety.

A pharmacy receives the following prescription: Auvi-Q 0.3 mg/0.3 mL Sig: 0.3 mg PO p.r.n. for severe allergic reaction Disp: 2 pack. The prescriber should be contacted to clarify the:

The prescriber should be contacted to clarify the route of administration.

Related Questions

Related Quizzes

How familiar were you with this question?

Report an Issue

Rate this Practice Test